DOCSLIB.ORG

Medical Bacteriology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medical Bacteriology LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology. Since it comprises most of the contents of course outline on medical bacteriology to nursing, pharmacy and environmental science students, it can be used as a main learning material to these category of students. This lecture note gives emphasis on the knowledge and procedures of medical bacteriology to common pathogens in our country. At last but not least, the quality of this lecture note is kept updated by continous comments made by users of this lecture note. Abilo Tadesse Meseret Alem i ACKNOWLEDGEMENT We would like to acknowledge the Carter Center, USA, for financial support for the preparation of this lecture note. Our deepest gratitude goes to Prof. Dennis Carlson for his invaluable technical and moral support for the completion of this work. We also extend our appreciation to those individuals who reviewed this lecture note in different teaching institutions for the materialization of this lecture note. ii TABLE OF CONTENTS Page Preface ………………………………………………………………...i Acknowledgement ……………………………………………………ii Table of Contents ....................................................................... iii List of tables .............................................................................. vii List of figures .............................................................................viii List of Abbreviation …………………………………………………..xi CHAPTER ONE 1.1. Introduction to Microbiology ................................... 1 1.2. The Microbial World ............................................... 5 1.3. Structure of bacteria ............................................ 12 1.4. Classification of bacteria ...................................... 23 1.5. Cultivation of bacteria .......................................... 33 1.6. Bacterial nutrition ……………………… ................ 47 1.7. Bacterial growth ................................................... 49 1.8. Bacterial genetics ................................................ 85 1.9. Sterilization and disinfection ................................ 92 1.10. Antimicrobial sensitivity testing ......................... 107 CHAPTER TWO Collection, transport, and examination of specimen ............... 113 iii CHAPTER THREE 3.1 Gram positive cocci .................................................... 173 3.1.1. Genus Staphylococci ...................................... 173 3.1.2. Genus Streptococci ........................................ 180 3.2 Gram positive spore forming rods ............................. 192 3.2.1. Genus Bacillus …………………… ................... 192 3.2.2. Genus Clostridium ....................................... 197 3.2.3. Gram positive Non-spore forming rods ........ 205 3.3.1. Genus Corynebacteria ..................................... 205 3.3.2. Genus Listeria .................................................. 210 3.3.3. Genus Erysipelothrix ........................................ 212 3.4 Gram negative diplococci ................................................ 213 3.4.1 Genus Neisseria ......................................... 213 3.5 Gram negative coccobacilli .............................................. 221 3.5.1 Genus Haemophilus ....................................... 221 3.5.2 Genus Bordetella ............................................. 224 3.5.3 Genus Brucella ................................................ 227 3.5.4 Genus Francissella .......................................... 229 3.5.5 Genus Pasteurella ........................................... 230 3.6 Gram negative rods ........................................................... 231 3.6.1 Genus Escherichia ................................................ 233 3.6.2. Genus Klebsiella ................................................... 235 3.6.3. Genus Enterobacter ............................................. 236 3.6.4. Genus Citrobacter ................................................ 237 3.6.5. Genus Salmonella ................................................ 237 3.6.6. Genus Shigella ..................................................... 242 3.6.7. Genus Proteus ...................................................... 244 3.6.8. Genus Yersinia ..................................................... 245 iv 3.6.9. Genus Peudomonas ............................................. 249 3.6.10 Genus Vibrios ...................................................... 252 3.6.11 Genus Campylobacter ....................................... 254 3.6.12 Genus Helicobacter ........................................... 256 3.7. Genus Mycobacteria ........................................................ 263 3.8. Spirochetes ...................................................................... 273 3.8.1.Genus Treponema ..................................................... 273 3.8.2 Genus Borellia ........................................................... 279 3.8.3 Genus Leptospira ....................................................... 281 3.9 Genus Rickettsia ............................................................... 282 3.10. Genus Mycoplasma ........................................................ 286 3.11. Genus Chlamydia ........................................................... 288 CHAPTER FOUR 4.1. Host-parasite relationship ............................................ 294 4.2. Normal microbial flora ................................................. 300 4.3. Infection of skin and wound ......................................... 304 4.4. Infection of respiratory tract ......................................... 307 4.5. Infection of gastrointestinal tract .................................. 313 4.6. Infection of urinary tract ............................................... 318 4.7. Infection of genital tract ............................................... 321 4.8. Infection of blood ......................................................... 325 4.9. Infection of central nervous system ............................ 327 4.10 Infection of bone and joint ........................................... 331 CHAPTER FIVE 5.1. Bacteriology of water ........................................................ 335 v CHAPTER SIX Food Bacteriology ................................................................... 341 Annexes .................................................................................... 375 Glossary .................................................................................. 429 References .............................................................................. 433 vi LIST OF TABLES Table1.1 The distinguishing features between eukaryotic and prokaryotic cell .......................................................... 11 Table 1.2 Comparison between flagella and pili ....................... 22 Table 2.1 Differentiation of staphylococcal species ................ 180 Table 2.2 Classification based on hemolytic reaction of Streptococci ............................................................. 183 Table 2.3 Comparison of streptolysin ...................................... 185 Table 2.4 Differentiation of streptococci species ..................... 192 Table 2.5 Comparison features of meningococcal meningitis and meningococcemia ................................................... 219 Table 2.6 Comparison features of N.gonorrhea and N. Meningitides ........................................................... 221 Table 2.7 Comparison between tuberculoid and lepromatous Leprosy ........................................................... 267 Table 2.8 Hosts and vectors of medically impotant rickettsiae 283 Table 4.1 Characteristic of bacterial toxin ............................... 295 Table 4.2 Examples of food intoxication ................................. 317 Table 4.3 Examples of food infection ...................................... 317 Table 4.4 Causative agents and disease of
Load more

Recommended publications
  • MINIATURIZED TECHNIQUES for Imvic TESTS1 DANIEL Y
    328 ]. Milk Food Technol., Vol. 35, No. 6 (1972) MINIATURIZED TECHNIQUES FOR IMViC TESTS1 DANIEL Y. c. FuNG AND RICHARD D. MILLER Department of Microbiology The Pennsylvania State University University Park 16802 ( Received for publication January 24, 1972) ABsTRACT Indole test Sterile tryptone broth ( Difco) was introduced into the A miniaturized method for performing IMViC tests is pro­ wells ( 0.2 ml per well) of a series of Microtiter plates; the Downloaded from http://meridian.allenpress.com/jfp/article-pdf/35/6/328/2399137/0022-2747-35_6_328.pdf by guest on 27 September 2021 posed. Twenty-four gram-negative bacterial species and plates were then inoculated, covered, and incubated at 37 C. strains were tested by use of miniaturized and conventional At intervals of 8, 12, and 24 hr, Microtiter plates were re­ methods; the results were comparable. The miniaturized moved from the incubator for testing. To detect indole pro­ method effects savingG of time, space, materials, and effort. duction, 2 drops of Kovac reagent were transferred by a The advantages and applications of microbiological Pasteur pipette to each well of the Microtiter plate. A red layer formed on top of the broth in the well indicated a posi~ tests using small volumes of media have been dis­ tive reaction. Parallel conventional tests for indole produc­ cussed in detail by Hartman (6). The combination tion, as well as other IMViC tests, were performed according of small volumes of media in Microtiter plates and to the Difm Manual (3), in each species and strain in four multiple inoculation techniques has been used by replicates.
    [Show full text]
  • A Mixture of Lactobacillus Plantarumcect 7315 and CECT
    Nutr Hosp. 2011;26(1):228-235 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318 Original A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial J. Mañé1,2*, E. Pedrosa1,2*, V. Lorén1,2, M. A. Gassull1,2, J. Espadaler3, J. Cuñé3, S. Audivert3, M. A. Bonachera3 and E. Cabré1,2,4 1Institute for Research in Health Sciences “Germans Trias i Pujol”. Badalona. Catalonia. Spain. 2Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). Barcelona. Spain. 3AB-Biotics. Cerdanyola del Vallès. Catalonia. Spain. 4Department of Gastroenterology. Hospital Universitari “Germans Trias i Pujol”. Badalona. Catalonia. Spain. *Contributed equally to the work. Abstract UNA MEZCLA DE LACTOBACILLUS PLANTARUM CECT 7315 Y CECT 7316 MEJORA LA INMUNIDAD Background & aim: Immunosenescence can increase SISTÉMICA EN ANCIANOS. UN ENSAYO morbi-mortality. Lactic acid producing bacteria may ALEATORIO PILOTO, DE DOSIS-RESPUESTA, improve immunity and reduce morbidity and mortality DOBLE CIEGO Y CONTROLADO CON PLACEBO in the elderly. We aimed to investigate the effects of a mix- ture of two new probiotic strains of Lactobacillus plan- tarum —CECT 7315 and 7316— on systemic immunity Resumen in elderly. Methods: 50 institutionalized elderly subjects were Introducción y objetivos: La inmunosenescencia puede randomized, in a double-blind fashion, to receive for 12 aumentar la morbi-mortalidad. Las bacterias producto- weeks 1) 5·108 cfu/day of L. plantarum CECT7315/7316 ras de ácido láctico pueden mejorar la inmunidad y dis- (“low probiotic dose”) (n = 13), 2) 5·109 cfu/day of the pro- minuir la morbilidad y mortalidad en los ancianos.
    [Show full text]
  • Prevalence of Urinary Tract Infection and Antibiotic Resistance Pattern in Pregnant Women, Najran Region, Saudi Arabia
    Vol. 13(26), pp. 407-413, August, 2019 DOI: 10.5897/AJMR2019.9084 Article Number: E3F64FA61643 ISSN: 1996-0808 Copyright ©2019 Author(s) retain the copyright of this article African Journal of Microbiology Research http://www.academicjournals.org/AJMR Full Length Research Paper Prevalence of urinary tract infection and antibiotic resistance pattern in pregnant women, Najran region, Saudi Arabia Ali Mohamed Alshabi1*, Majed Saeed Alshahrani2, Saad Ahmed Alkahtani1 and Mohammad Shabib Akhtar1 1Department of Clinical Pharmacy, College of Pharmacy, Najran University, Najran, Saudi Arabia. 2Department of Obstetics and Gyneocology, Faculty of Medicine, Najran University, Najran, Saudi Arabia. Received 25 February, 2019; Accepted August 5, 2019 Urinary Tract Infection (UTI) is one of the commonest infectious disease in pregnancy, and in pregnancy we have very limited number of antibiotics to treat the UTI. This study was conducted on 151 patients who attended the gynecology clinic during the study period. Nineteen UTI proven cases of UTI were studied for prevalence of microorganism and sensitivity pattern against different antibiotics. Among the bacteria isolated, Escherichia coli (73.68%) and Staphylococcus aureus (10.52%) were the most prevalent Gram negative and Gram positive bacteria respectively. To know the resistance pattern of microorganism we used commercially available discs of different antibiotics. Gram negative bacteria showed more resistance as compared to Gram positive one. It is observed that the most effective antibiotic for Gram negative isolates is Ceftriaxone (87.5%), followed by Amoxicillin + Clavulanic acid (81.25%), Amikacin (75%), Cefuroxime (75%), Cefixime (68.75%) and Mezlocillin (62.5%). For the Gram positive bacteria, Ceftriaxone, Amikacin and Amoxicillin + Clavulanic acid were the most effective antimicrobials (100%).
    [Show full text]
  • Catalogue of Bacteria Shapes
    We first tried to use the most general shape associated with each genus, which are often consistent across species (spp.) (first choice for shape). If there was documented species variability, either the most common species (second choice for shape) or well known species (third choice for shape) is shown. Corynebacterium: pleomorphic bacilli. Due to their snapping type of division, cells often lie in clusters resembling chinese letters (https://microbewiki.kenyon.edu/index.php/Corynebacterium) Shown is Corynebacterium diphtheriae Figure 1. Stained Corynebacterium cells. The "barred" appearance is due to the presence of polyphosphate inclusions called metachromatic granules. Note also the characteristic "Chinese-letter" arrangement of cells. (http:// textbookofbacteriology.net/diphtheria.html) Lactobacillus: Lactobacilli are rod-shaped, Gram-positive, fermentative, organotrophs. They are usually straight, although they can form spiral or coccobacillary forms under certain conditions. (https://microbewiki.kenyon.edu/index.php/ Lactobacillus) Porphyromonas: A genus of small anaerobic gram-negative nonmotile cocci and usually short rods thatproduce smooth, gray to black pigmented colonies the size of which varies with the species. (http:// medical-dictionary.thefreedictionary.com/Porphyromonas) Shown: Porphyromonas gingivalis Moraxella: Moraxella is a genus of Gram-negative bacteria in the Moraxellaceae family. It is named after the Swiss ophthalmologist Victor Morax. The organisms are short rods, coccobacilli or, as in the case of Moraxella catarrhalis, diplococci in morphology (https://en.wikipedia.org/wiki/Moraxella). *This one could be changed to a diplococcus shape because of moraxella catarrhalis, but i think the short rods are fair given the number of other moraxella with them. Jeotgalicoccus: Jeotgalicoccus is a genus of Gram-positive, facultatively anaerobic, and halotolerant to halophilicbacteria.
    [Show full text]
  • Porphyromonas Gingivalis, Strain F0566 Catalog
    Product Information Sheet for HM-1141 Porphyromonas gingivalis, Strain F0566 immediately upon arrival. For long-term storage, the vapor phase of a liquid nitrogen freezer is recommended. Freeze- thaw cycles should be avoided. Catalog No. HM-1141 Growth Conditions: For research use only. Not for human use. Media: Supplemented Tryptic Soy broth or equivalent Contributor: Tryptic Soy agar with 5% defibrinated sheep blood or Floyd E. Dewhirst, D.D.S., Ph.D., Senior Member of the Staff, Supplemented Tryptic Soy agar or equivalent Department of Microbiology and Jacques Izard, Assistant Incubation: Member of the Staff, Department of Molecular Genetics, The Temperature: 37°C Forsyth Institute, Cambridge, Massachusetts, USA Atmosphere: Anaerobic Propagation: Manufacturer: 1. Keep vial frozen until ready for use, then thaw. BEI Resources 2. Transfer the entire thawed aliquot into a single tube of broth. Product Description: 3. Use several drops of the suspension to inoculate an Bacteria Classification: Porphyromonadaceae, agar slant and/or plate. Porphyromonas 4. Incubate the tube, slant and/or plate at 37°C for 24 to Species: Porphyromonas gingivalis 72 hours. Broth cultures should include shaking. Strain: F0566 Original Source: Porphyromonas gingivalis (P. gingivalis), Citation: strain F0566 was isolated in October 1987 from the tooth Acknowledgment for publications should read “The following of a patient diagnosed with moderate periodontitis in the reagent was obtained through BEI Resources, NIAID, NIH as United States.1 part of the Human Microbiome Project: Porphyromonas Comments: P. gingivalis, strain F0566 (HMP ID 1989) is a gingivalis, Strain F0566, HM-1141.” reference genome for The Human Microbiome Project (HMP). HMP is an initiative to identify and characterize Biosafety Level: 2 human microbial flora.
    [Show full text]
  • Introduction to Bacteriology and Bacterial Structure/Function
    INTRODUCTION TO BACTERIOLOGY AND BACTERIAL STRUCTURE/FUNCTION LEARNING OBJECTIVES To describe historical landmarks of medical microbiology To describe Koch’s Postulates To describe the characteristic structures and chemical nature of cellular constituents that distinguish eukaryotic and prokaryotic cells To describe chemical, structural, and functional components of the bacterial cytoplasmic and outer membranes, cell wall and surface appendages To name the general structures, and polymers that make up bacterial cell walls To explain the differences between gram negative and gram positive cells To describe the chemical composition, function and serological classification as H antigen of bacterial flagella and how they differ from flagella of eucaryotic cells To describe the chemical composition and function of pili To explain the unique chemical composition of bacterial spores To list medically relevant bacteria that form spores To explain the function of spores in terms of chemical and heat resistance To describe characteristics of different types of membrane transport To describe the exact cellular location and serological classification as O antigen of Lipopolysaccharide (LPS) To explain how the structure of LPS confers antigenic specificity and toxicity To describe the exact cellular location of Lipid A To explain the term endotoxin in terms of its chemical composition and location in bacterial cells INTRODUCTION TO BACTERIOLOGY 1. Two main threads in the history of bacteriology: 1) the natural history of bacteria and 2) the contagious nature of infectious diseases, were united in the latter half of the 19th century. During that period many of the bacteria that cause human disease were identified and characterized. 2. Individual bacteria were first observed microscopically by Antony van Leeuwenhoek at the end of the 17th century.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,304,196 B2 Caprioli (45) Date of Patent: *Nov
    USOO83 041.96B2 (12) United States Patent (10) Patent No.: US 8,304,196 B2 Caprioli (45) Date of Patent: *Nov. 6, 2012 (54) INSITUANALYSIS OF TISSUES 6,809,315 B2 10/2004 Ellson et al. .................. 250/288 7,534.338 B2 5/2009 Hafeman et al. ... 205/288 O O 2003.0049701 A1* 3, 2003 Muraca .......... 435/723 (75) Inventor: Richard Caprioli, Brentwood, TN (US) 2003/0186287 A1 10, 2003 Lin et al. 435/6 2004.0007673 A1* 1 2004 Coon et al. .. 250,424 (73) Assignee: Vanderbilt University, Nashville, TN 2007/0082356 A1 4/2007 Strom et al. ...................... 435/6 (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this WO WOO1,26460 4/2001 patent is extended or adjusted under 35 WO WOO3,O34024 4/2003 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS This patent is Subject to a terminal dis- Schwartz et al. (J. Mass Spectrometry 2003 vol. 38, p. 699-708).* claimer. Pauletti et al. (J. Clin. Oncology 2000 vol. 18, 3651-3664).* Office Action issued in U.S. Appl. No. 1 1/355.912, mailed Apr. 3, (21) Appl. No.: 12/942,840 2008. Office Action issued in U.S. Appl. No. 1 1/355.912, mailed Dec. 8, 1-1. 2009. (22) Filed: Nov. 9, 2010 Office Action issued in U.S. Appl. No. 1 1/355.912, mailed May 22, O O 2009. (65) Prior Publication Data Yanagisawa et al., “Proteomic patterns of tumour Subsets in non US 2011 FO190145 A1 Aug. 4, 2011 Small-cell lung cancer.” The Lancet, 362:433-439, 2003.
    [Show full text]
  • Peraturan Badan Pengawas Obat Dan Makanan Nomor 28 Tahun 2019 Tentang Bahan Penolong Dalam Pengolahan Pangan
    BADAN PENGAWAS OBAT DAN MAKANAN REPUBLIK INDONESIA PERATURAN BADAN PENGAWAS OBAT DAN MAKANAN NOMOR 28 TAHUN 2019 TENTANG BAHAN PENOLONG DALAM PENGOLAHAN PANGAN DENGAN RAHMAT TUHAN YANG MAHA ESA KEPALA BADAN PENGAWAS OBAT DAN MAKANAN, Menimbang : a. bahwa masyarakat perlu dilindungi dari penggunaan bahan penolong yang tidak memenuhi persyaratan kesehatan; b. bahwa pengaturan terhadap Bahan Penolong dalam Peraturan Kepala Badan Pengawas Obat dan Makanan Nomor 10 Tahun 2016 tentang Penggunaan Bahan Penolong Golongan Enzim dan Golongan Penjerap Enzim dalam Pengolahan Pangan dan Peraturan Kepala Badan Pengawas Obat dan Makanan Nomor 7 Tahun 2015 tentang Penggunaan Amonium Sulfat sebagai Bahan Penolong dalam Proses Pengolahan Nata de Coco sudah tidak sesuai dengan kebutuhan hukum serta perkembangan ilmu pengetahuan dan teknologi sehingga perlu diganti; c. bahwa berdasarkan pertimbangan sebagaimana dimaksud dalam huruf a dan huruf b, perlu menetapkan Peraturan Badan Pengawas Obat dan Makanan tentang Bahan Penolong dalam Pengolahan Pangan; -2- Mengingat : 1. Undang-Undang Nomor 18 Tahun 2012 tentang Pangan (Lembaran Negara Republik Indonesia Tahun 2012 Nomor 227, Tambahan Lembaran Negara Republik Indonesia Nomor 5360); 2. Peraturan Pemerintah Nomor 28 Tahun 2004 tentang Keamanan, Mutu dan Gizi Pangan (Lembaran Negara Republik Indonesia Tahun 2004 Nomor 107, Tambahan Lembaran Negara Republik Indonesia Nomor 4424); 3. Peraturan Presiden Nomor 80 Tahun 2017 tentang Badan Pengawas Obat dan Makanan (Lembaran Negara Republik Indonesia Tahun 2017 Nomor 180); 4. Peraturan Badan Pengawas Obat dan Makanan Nomor 12 Tahun 2018 tentang Organisasi dan Tata Kerja Unit Pelaksana Teknis di Lingkungan Badan Pengawas Obat dan Makanan (Berita Negara Republik Indonesia Tahun 2018 Nomor 784); MEMUTUSKAN: Menetapkan : PERATURAN BADAN PENGAWAS OBAT DAN MAKANAN TENTANG BAHAN PENOLONG DALAM PENGOLAHAN PANGAN.
    [Show full text]
  • Toxicological Profile for Phenol
    PHENOL 21 3. HEALTH EFFECTS 3.1 INTRODUCTION The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and other interested individuals and groups with an overall perspective on the toxicology of phenol. It contains descriptions and evaluations of toxicological studies and epidemiological investigations and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic data to public health. It should be noted that phenol is the simplest form, or parent compound, of the class of chemicals commonly referred to as phenols or phenolics, many of which are natural substances widely distributed throughout the environment. There is some confusion in the literature as to the use of the term ‘phenol’; in some cases, it has been used to refer to a particular phenolic compound that is more highly substituted than the parent compound (Doan et al. 1979), whereas in other cases, it has been used to refer to the class of phenolic compounds (Beveridge 1997). This chapter, however, addresses only those health effects that can be directly attributable to the parent compound, monohydroxybenzene, or phenol. As Deichmann and Keplinger (1981) note: “It cannot be overemphasized that the structure-activity relationships of phenol and phenol derivatives vary widely, and that to accept the properties of individual phenolic compounds as being those of phenol is a misconception and leads to error and confusion.” A glossary and list of acronyms, abbreviations, and symbols can be found in Appendix C at the end of this profile. 3.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE To help public health professionals and others address the needs of persons living or working near hazardous waste sites, the information in this section is organized first by route of exposure (inhalation, oral, and dermal) and then by health effect (death, systemic, immunological, neurological, reproductive, developmental, genotoxic, and carcinogenic effects).
    [Show full text]
  • A Randomized, Double-Blind Clinical Trial
    DOI: 10.1590/0100-69912017006004 Original Article Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial A administração perioperatória de simbióticos em pacientes com câncer colorretal reduz a incidência de infecções pós-operatórias: ensaio clínico randomizado duplo-cego ALINE TABORDA FLESCH1; STAEL T. TONIAL1; PAULO DE CARVALHO CONTU1; DANIEL C. DAMIN1. ABSTRACT Objective: to evaluate the effect of perioperative administration of symbiotics on the incidence of surgical wound infection in patients undergoing surgery for colorectal cancer. Methods: We conducted a randomized clinical trial with colorectal cancer patients undergoing elective surgery, randomly assigned to receive symbiotics or placebo for five days prior to the surgical procedure and for 14 days after surgery. We studied 91 patients, 49 in the symbiotics group (Lactobacillus acidophilus 108 to 109 CFU, Lactobacillus rhamnosus 108 to 109 CFU, Lactobacillus casei 108 to 109 CFU, Bifi dobacterium 108 to 109 CFU and fructo-oligosaccharide (FOS) 6g) and 42 in the placebo group. Results: surgical site infection occurred in one (2%) patient in the symbiotics group and in nine (21.4%) patients in the control group (p=0.002). There were three cases of intraabdominal abscess and four cases of pneumonia in the control group, whereas we observed no infections in patients receiving symbiotics (p=0.001). Conclusion: the perioperative administration of symbiotics significantly reduced postoperative infection rates in patients with colorectal cancer. Additional studies are needed to confirm the role of symbiotics in the surgical treatment of colorectal cancer. Keywords: Synbiotics. Infection. Colorectal Surgery. Colorectal Neoplasms. Clinical Trial. INTRODUCTION an important reservoir for commensal microorganisms, the use of symbiotics in colorectal surgery is controver- espite the recent advances in colorectal surgery, sial10-12.
    [Show full text]
  • Acqueous Parachlorophenol: Its Toxicity and Antimicrobial Effectiveness
    Loyola University Chicago Loyola eCommons Master's Theses Theses and Dissertations 1969 Acqueous Parachlorophenol: Its Toxicity and Antimicrobial Effectiveness John W. Harrison Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_theses Part of the Medicine and Health Sciences Commons Recommended Citation Harrison, John W., "Acqueous Parachlorophenol: Its Toxicity and Antimicrobial Effectiveness" (1969). Master's Theses. 2367. https://ecommons.luc.edu/luc_theses/2367 This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 1969 John W. Harrison ACQUEOUS PAHACB.lil')HOPHENOL: I'I'S TOXICITY AND AN'I'IMICROBIAL EFFECTIVENESS by John Wylie Harrison, B.&., D.M.D. A Thesis Submitted to the Faculty of the Graduate School of Loyola University in Partial Fulfillment of the Requirements for the Degree of Master of Science June 1969 lftrary · · Loyora University Medical <:enbl Acknowledgements There are many people who deserve thanks for their assistance in the myriad of problems which inevitably arise in a research project of this na­ ture. I can only hope that my sincere gratitude for their efforts has been made personally evident. I am particularly indebted to B. Franklin Gurney, B.S., M.s •• D.D.S., F.A.C.D., for suggesting certain ideas which eventually led to the choice of this par­ ticular problem as a research project; and to Norman K.
    [Show full text]
  • New Methods for Pathogens : a Revlew Daniel Y
    234 NEW METHODS FOR PATHOGENS : A REVLEW DANIEL Y. C. FUNG The Pennsylvania State University Intr ductioii Interests in new methods for identification of bacterial pathogens have increased greatly in recent years due to the awareness of, the need for, and the potential of rapid methods and automation in Micro- biology. In 1971 a report by the U .So National Institute of General Medical Sciences presented the status of mechanization and automation in the clinical laboratory; autcnnation in microbiology was one of the topics reviewed (Kinney, 19-71). Richardson (1972) summttrized the developments of automation in the dairy Laboratories. These topics have been discussed in detail in the International Symposium on Rapid Methods and Automation in Microbiology first held L~IStockholm, Sweden, 1973, and again in Cambridge University, England, 1976. Another symposium was held in Kiel, Germny, 1974 with the title Automation of Microbio1ogr;ical Food Analysis. TheIn proceedings of the First International Symposium were published in two volumes : Automation in Microbiology and Innrmnolom (Heden and Illeni, 1975a) and New Approaches to the Identification of Microorganisms (Heden and Illeni, 1975b). The purpose of this article is to summarize the highlights of some automated microbiological tests and rapid methods relevant to the food industry. Hopefully some of these methods could be adapted and used routinely by the food industry. New Approaches and Automation in Microbioloa Generally the approach to developing new nethods for pathogens involved either a search for new ideas and related instrument develop- ment or improvement of existing bacteriological methods. The impetus for the development of new ideas and instruments mbly comes from clinical needs for rapid detection of organisms and antibiotic sensitivity testing.
    [Show full text]